388 related articles for article (PubMed ID: 14727129)
1. The calcineurin signal transduction pathway is essential for successful muscle regeneration in mdx dystrophic mice.
Stupka N; Gregorevic P; Plant DR; Lynch GS
Acta Neuropathol; 2004 Apr; 107(4):299-310. PubMed ID: 14727129
[TBL] [Abstract][Full Text] [Related]
2. Differential calcineurin signalling activity and regeneration efficacy in diaphragm and limb muscles of dystrophic mdx mice.
Stupka N; Michell BJ; Kemp BE; Lynch GS
Neuromuscul Disord; 2006 May; 16(5):337-46. PubMed ID: 16621557
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.
Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G
Exp Neurol; 2006 Mar; 198(1):234-41. PubMed ID: 16410003
[TBL] [Abstract][Full Text] [Related]
4. Muscle weakness and atrophy are associated with decreased regenerative capacity and changes in mTOR signaling in skeletal muscles of venerable (18-24-month-old) dystrophic mdx mice.
Mouisel E; Vignaud A; Hourdé C; Butler-Browne G; Ferry A
Muscle Nerve; 2010 Jun; 41(6):809-18. PubMed ID: 20151467
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice.
Chakkalakal JV; Harrison MA; Carbonetto S; Chin E; Michel RN; Jasmin BJ
Hum Mol Genet; 2004 Feb; 13(4):379-88. PubMed ID: 14681302
[TBL] [Abstract][Full Text] [Related]
6. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
7. Age-related differences in regeneration of dystrophic (mdx) and normal muscle in the mouse.
Pastoret C; Sebille A
Muscle Nerve; 1995 Oct; 18(10):1147-54. PubMed ID: 7659109
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin/NF-AT pathway.
St-Pierre SJ; Chakkalakal JV; Kolodziejczyk SM; Knudson JC; Jasmin BJ; Megeney LA
FASEB J; 2004 Dec; 18(15):1937-9. PubMed ID: 15456738
[TBL] [Abstract][Full Text] [Related]
9. Administration of insulin-like growth factor-I improves fatigue resistance of skeletal muscles from dystrophic mdx mice.
Gregorevic P; Plant DR; Lynch GS
Muscle Nerve; 2004 Sep; 30(3):295-304. PubMed ID: 15318340
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy.
Marques MJ; Ferretti R; Vomero VU; Minatel E; Neto HS
Muscle Nerve; 2007 Mar; 35(3):349-53. PubMed ID: 17143878
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
[TBL] [Abstract][Full Text] [Related]
12. Nerve terminal contributes to acetylcholine receptor organization at the dystrophic neuromuscular junction of mdx mice.
Marques MJ; Taniguti AP; Minatel E; Neto HS
Anat Rec (Hoboken); 2007 Feb; 290(2):181-7. PubMed ID: 17441210
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A treatment upregulates Id1 and Smad3 expression and delays skeletal muscle regeneration.
Sakuma K; Nakao R; Aoi W; Inashima S; Fujikawa T; Hirata M; Sano M; Yasuhara M
Acta Neuropathol; 2005 Sep; 110(3):269-80. PubMed ID: 15986223
[TBL] [Abstract][Full Text] [Related]
14. Phenotype of dystrophinopathy in old mdx mice.
Lefaucheur JP; Pastoret C; Sebille A
Anat Rec; 1995 May; 242(1):70-6. PubMed ID: 7604983
[TBL] [Abstract][Full Text] [Related]
15. The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice.
Messina S; Bitto A; Aguennouz M; Vita GL; Polito F; Irrera N; Altavilla D; Marini H; Migliorato A; Squadrito F; Vita G
Neuromuscul Disord; 2011 Aug; 21(8):579-89. PubMed ID: 21658942
[TBL] [Abstract][Full Text] [Related]
16. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
Montgomery E; Pennington C; Isales CM; Hamrick MW
Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
[TBL] [Abstract][Full Text] [Related]
17. T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse.
Farini A; Meregalli M; Belicchi M; Battistelli M; Parolini D; D'Antona G; Gavina M; Ottoboni L; Constantin G; Bottinelli R; Torrente Y
J Pathol; 2007 Oct; 213(2):229-38. PubMed ID: 17668421
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of deltaCaMKII isoforms in skeletal muscle regeneration: Implications in dystrophic muscle disease.
Abraham ST; Shaw C
J Cell Biochem; 2006 Feb; 97(3):621-32. PubMed ID: 16215994
[TBL] [Abstract][Full Text] [Related]
19. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
Schertzer JD; Ryall JG; Lynch GS
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of calcineurin Aalpha activity attenuates muscle pathophysiology in mdx dystrophic mice.
Stupka N; Schertzer JD; Bassel-Duby R; Olson EN; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R983-92. PubMed ID: 18199592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
